Limits...
Prospective cohort study protocol to describe the transfer of patients from intensive care units to hospital wards.

Buchner DL, Bagshaw SM, Dodek P, Forster AJ, Fowler RA, Lamontagne F, Turgeon AF, Potestio M, Stelfox HT - BMJ Open (2015)

Bottom Line: The transfer of patient care between the intensive care unit (ICU) and the hospital ward is associated with increased risk of medical error and adverse events.We will abstract information from patient health records to identify clinical data and use of transfer tools, and identify adverse events that are related to the transfer.Dissemination of the findings will provide a comprehensive description of transfer from ICU to hospital ward in Canada including the uptake of validated or local transfer tools, a conceptual framework of the experiences and needs of stakeholders in the ICU transfer process, a summary of adverse events experienced by patients after transfer from ICU to hospital ward, and opportunities to guide quality improvement efforts.

View Article: PubMed Central - PubMed

Affiliation: Faculty of Medicine, University of Calgary, Calgary, Canada.

No MeSH data available.


ACE Capacity to Consent Screening Tool.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4499701&req=5

BMJOPEN2015007913F1: ACE Capacity to Consent Screening Tool.

Mentions: The patients’ capacity to provide informed consent will be determined by a modified Aid to Capacity to Evaluation tool52 (figure 1). If the patient does not demonstrate capacity to consent, we will attempt to identify a suitable surrogate to provide informed consent. Healthcare provider's consent will be gathered from implied or written consent depending on the study location. Implied consent will be explained on the cover sheet of healthcare provider surveys.


Prospective cohort study protocol to describe the transfer of patients from intensive care units to hospital wards.

Buchner DL, Bagshaw SM, Dodek P, Forster AJ, Fowler RA, Lamontagne F, Turgeon AF, Potestio M, Stelfox HT - BMJ Open (2015)

ACE Capacity to Consent Screening Tool.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4499701&req=5

BMJOPEN2015007913F1: ACE Capacity to Consent Screening Tool.
Mentions: The patients’ capacity to provide informed consent will be determined by a modified Aid to Capacity to Evaluation tool52 (figure 1). If the patient does not demonstrate capacity to consent, we will attempt to identify a suitable surrogate to provide informed consent. Healthcare provider's consent will be gathered from implied or written consent depending on the study location. Implied consent will be explained on the cover sheet of healthcare provider surveys.

Bottom Line: The transfer of patient care between the intensive care unit (ICU) and the hospital ward is associated with increased risk of medical error and adverse events.We will abstract information from patient health records to identify clinical data and use of transfer tools, and identify adverse events that are related to the transfer.Dissemination of the findings will provide a comprehensive description of transfer from ICU to hospital ward in Canada including the uptake of validated or local transfer tools, a conceptual framework of the experiences and needs of stakeholders in the ICU transfer process, a summary of adverse events experienced by patients after transfer from ICU to hospital ward, and opportunities to guide quality improvement efforts.

View Article: PubMed Central - PubMed

Affiliation: Faculty of Medicine, University of Calgary, Calgary, Canada.

No MeSH data available.